{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:26:10Z","timestamp":1772252770564,"version":"3.50.1"},"reference-count":39,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["STSC20001"],"award-info":[{"award-number":["STSC20001"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K09840"],"award-info":[{"award-number":["19K09840"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Background\/Aim: Patients with uterine sarcoma comprise 2\u20135% of all patients with uterine malignancies; however, the morbidity of uterine sarcoma is low compared with that of other gynecological cancers. For many cases, malignant uterine tumors are diagnosed during follow-up of benign uterine leiomyoma. Of the uterine sarcomas, rhabdomyosarcoma is considered a mixed tumor containing components of epithelial cells and mesenchymal cells. Therefore, the onset of primary uterine rhabdomyosarcoma during follow-up of uterine leiomyoma is extremely rare. Rhabdomyosarcoma is a relatively common malignant tumor in children, but rhabdomyosarcoma in adults is extremely rare, accounting for approximately 3% of all patients with soft tissue sarcoma. Rhabdomyosarcoma in children is highly sensitive to chemotherapy and radiation therapy; however, the response to chemotherapy and radiation therapy in adult rhabdomyosarcoma is low and survival in adult rhabdomyosarcoma with metastatic lesions to other organs is approximately 14 months. We experienced a case of pleomorphic rhabdomyosarcoma during the follow-up of a uterine leiomyoma. Materials and Methods: We examined the oncological properties of uterine rhabdomyosarcoma in adults using molecular pathological techniques on tissue excised from patients with uterine leiomyoma. Result: A differential diagnosis was made for this case by molecular pathology, which included candidate biomarkers for uterine smooth muscle tumors. The oncological nature of uterine rhabdomyosarcoma was found to be similar to the oncological properties of uterine leiomyosarcoma. However, in uterine rhabdomyosarcoma, LMP2\/\u03b21i-positive cells were clearly observed. Conclusion: It is expected that establishing a diagnostic and treatment method targeting characteristics of mesenchymal tumor cells will lead to the treatment of malignant tumors with a low risk of recurrence and metastasis.<\/jats:p>","DOI":"10.3390\/curroncol29040190","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T21:40:14Z","timestamp":1648590014000},"page":"2350-2363","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Characteristic of Uterine Rhabdomyosarcoma by Algorithm of Potential Biomarkers for Uterine Mesenchymal Tumor"],"prefix":"10.3390","volume":"29","author":[{"given":"Saya","family":"Tamura","sequence":"first","affiliation":[{"name":"National Hospital Organization Kyoto Medical Center, Department of Obstetrics and Gynecology, Kyoto 612-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7525-2048","authenticated-orcid":false,"given":"Takuma","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Section of Cancer Medicine, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"},{"name":"START-Program, Japan Science and Technology Agency (JST), Tokyo 102-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Ichimura","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Osaka City University School of Medicine, Osaka 545-8586, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Yaegashi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tohoku University School of Medicine, Miyagi 980-8575, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Abiko","sequence":"additional","affiliation":[{"name":"National Hospital Organization Kyoto Medical Center, Department of Obstetrics and Gynecology, Kyoto 612-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuo","family":"Konishi","sequence":"additional","affiliation":[{"name":"National Hospital Organization Kyoto Medical Center, Department of Obstetrics and Gynecology, Kyoto 612-8555, Japan"},{"name":"Department of Obstetrics and Gynecology, Kyoto University School of Medicine, Kyoto 606-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"key":"ref_1","unstructured":"WHO Classification of Tumours Editorial Board (2020). Mesenchymal tumours of the lower genital tract. Female Genital Tumours WHO Classification of Tumours, World Health Organization. [5th ed.]."},{"key":"ref_2","unstructured":"WHO Classification of Tumours Editorial Board (2020). Uterine leiomyosarcoma. Female Genital Tumours, World Health Organization."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004347-199204000-00001","article-title":"Adenosarcoma of the uterus: A Gynecologic Oncology Group clinicopathologic study of 31 cases","volume":"11","author":"Kaku","year":"1992","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ygyno.2010.07.001","article-title":"Long-term outcome and natural history of uterine adenosarcomas","volume":"119","author":"Arend","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0046-8177(90)90198-E","article-title":"Mullerian adenosarcoma of the uterus: A clinicopathologic analysis of 100 cases with a review of the literature","volume":"21","author":"Clement","year":"1990","journal-title":"Hum. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11912-016-0552-7","article-title":"Uterine Adenosarcoma: A Review","volume":"18","author":"Nathenson","year":"2016","journal-title":"Curr. Oncol. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1038\/modpathol.2015.139","article-title":"Practical issues in uterine pathology from banal to bewildering: The remarkable spectrum of smooth muscle neoplasia","volume":"29","author":"Oliva","year":"2016","journal-title":"Mod. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/PAS.0b013e318161d1be","article-title":"Mullerian adenosarcomas: An immunophenotypic analysis of 35 cases","volume":"32","author":"Soslow","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/IGC.0000000000001183","article-title":"Female Sex Hormone Receptor Profiling in Uterine Adenosarcomas","volume":"28","author":"Marcus","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_10","unstructured":"(2016, May 27). Cytopathology Glossary\u2014Edited Cytopathology Glossary Committee of the Japanese Society of Clinical Cytology, 27 May 2016. Available online: http:\/\/jscc.or.jp\/wp-content\/uploads\/2015\/05\/kaisetsu.pdf."},{"key":"ref_11","unstructured":"WHO Classification of Tumours Editorial Board (2020). Rhabdomyosarcoma. Female Genital Tumours, World Health Organization."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1038\/sj.onc.1209434","article-title":"The mutation in the ATP binding region of JAK1, identified in human uterine leiomyosarcomas, results in defective interferon-gamma inducibility of TAP1 and LMP","volume":"25","author":"Hayashi","year":"2006","journal-title":"Oncogene"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.bbrc.2015.06.046","article-title":"Expression of CAVEOLIN 1 in uterine mesenchymal tumors: No relationship between malignancy and CAVEOLIN 1 expression","volume":"463","author":"Hayashi","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.21873\/anticanres.15082","article-title":"Development of Uterine Leiomyosarcoma During Follow-up After Caesarean Section in a Woman with Uterine Leiomyoma","volume":"41","author":"Watanabe","year":"2021","journal-title":"Anticancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3390\/cimb43020084","article-title":"Oncological Features of Intravenous Leiomyomatosis: Involvement of Mesenchymal Tumor Stem-Like Cells","volume":"43","author":"Tamura","year":"2021","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/PGP.0b013e318249285b","article-title":"Uterine adenosarcomas: Diagnostic use of the proliferation marker Ki-67 as an adjunct to morphologic diagnosis","volume":"31","author":"Aggarwal","year":"2012","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_17","first-page":"24","article-title":"Development of spontaneous uterine tumors in low molecular mass polypeptide-2 knockout mice","volume":"62","author":"Hayashi","year":"2002","journal-title":"Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s13238-010-0095-x","article-title":"Mice-lacking LMP2, immuno-proteasome subunit, as an animal model of spontaneous uterine leiomyosarcoma","volume":"1","author":"Hayashi","year":"2010","journal-title":"Protein Cell."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/srep00180","article-title":"Potential role of LMP2 as tumor-suppressor defines new targets for uterine leiomyosarcoma therapy","volume":"1","author":"Hayashi","year":"2011","journal-title":"Sci. Rep."},{"key":"ref_20","unstructured":"(2019, December 04). Patent: Detection of Uterine Leiomyosarcoma Using LMPApplication JP2007548042A Events. Available online: https:\/\/upload.umin.ac.jp\/cgi-open-bin\/ctr\/ctr_view.cgi?recptno=R000044182."},{"key":"ref_21","first-page":"604","article-title":"Diagnostic biomarker candidates including NT5DC2 for human uterine mesenchymal tumors","volume":"5","author":"Hayashi","year":"2021","journal-title":"Int. J. Trend Sci. Res. Dev."},{"key":"ref_22","unstructured":"WHO Classification of Tumours Editorial Board (2020). Smooth muscle tumor of uncertain malignant potential of the uterine corpus. Female Genital Tumours, World Health Organization."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.21873\/anticanres.11509","article-title":"Characterization of Leiomyomatoid Angiomatous Neuroendocrine Tumour (LANT)-like Tumour in the Myometrium with Histopathological Examination","volume":"37","author":"Hayashi","year":"2017","journal-title":"Anticancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/00000478-200109000-00005","article-title":"Are myogenin and myoD1 expressionspecific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics","volume":"25","author":"Cessna","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/1346-8138.13549","article-title":"Case of pleomorphic rhabdomyosarcoma arising on subcutaneous tissue in an adult patient: Review of the published works of 13 cases arising on cutaneous or subcutaneous tissue","volume":"44","author":"Watanabe","year":"2017","journal-title":"J. Dermatol."},{"key":"ref_26","first-page":"985","article-title":"Rhabdomyosarcoma","volume":"52","author":"Yoshida","year":"2011","journal-title":"Pediatrics"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1200\/JCO.1995.13.3.610","article-title":"The third intergroup rhabdomyosarcoma study","volume":"13","author":"Crist","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00004347-199401000-00008","article-title":"Mural nodules in common epithelial tumors of the ovary","volume":"13","author":"Baergen","year":"1994","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_29","unstructured":"WHO Classification of Tumours Editorial Board (2020). Mucinous borderline tumour. Female Genital Tumours, World Health Organization."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1111\/jcmm.16409","article-title":"NT5DC2 promotes leiomyosarcoma tumour cell growth via stabilizing unpalmitoylated TEAD4 and generating a positive feedback loop","volume":"25","author":"Hu","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"An, Y., Wang, S., Li, S., Zhang, L., Wang, D., Wang, H., Zhu, S., Zhu, W., Li, Y., and Chen, W. (2017). Distinct molecular subtypes of uterine leiomyosarcoma respond differently to chemotherapy treatment. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3568-y"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/modpathol.2012.203","article-title":"MED12 mutations in leiomyosarcoma and extrauterine leiomyoma","volume":"26","author":"Ravegnini","year":"2013","journal-title":"Mod. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.humpath.2018.01.007","article-title":"Uterine rhabdomyosarcoma in adults","volume":"74","author":"Pinto","year":"2018","journal-title":"Hum. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/gcc.2870020103","article-title":"Uterine leiomyoma cytogenetics","volume":"2","author":"Nibert","year":"1990","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/1097-0142(195207)5:4<727::AID-CNCR2820050412>3.0.CO;2-H","article-title":"Rhabdomyosarcoma of the corpus uteri: Report of a case, associated with adenocarcinoma of the cervix, with review of the literature","volume":"5","author":"Kulka","year":"1952","journal-title":"Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/0002-9378(71)90258-4","article-title":"Malignant mixed mesodermal tumor of the uterus: An ultrastructural study","volume":"10","author":"Silverberg","year":"1971","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/B978-0-12-385940-2.00002-4","article-title":"Developmental origins of fusion-negative rhabdomyosarcomas","volume":"96","author":"Kikuchi","year":"2011","journal-title":"Curr. Top. Dev. Biol."},{"key":"ref_38","first-page":"3000605211014360","article-title":"Diagnosis and treatment of pleomorphic rhabdomyosarcoma of the uterus: A rare case report and review of the literature","volume":"49","author":"Li","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00428-020-02870-0","article-title":"Epithelioid and spindle cell rhabdomyosarcoma with FUS-TFCP2 or EWSR1-TFCP2 fusion: Report of two cases","volume":"477","author":"Chrisinger","year":"2020","journal-title":"Virchows Arch."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/29\/4\/190\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:44:38Z","timestamp":1760136278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/29\/4\/190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["curroncol29040190"],"URL":"https:\/\/doi.org\/10.3390\/curroncol29040190","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints202203.0091.v1","asserted-by":"object"}]},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,28]]}}}